# Early Palliative Care for Patients With Haematological Malignancies

> **NCT03800095** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 140 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Diffuse Large B Cell Lymphoma
- Palliative Care

## Interventions

- **DRUG:** Early palliative care integration

## Key facts

- **NCT ID:** NCT03800095
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-14
- **Primary completion:** 2023-08-14
- **Final completion:** 2023-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2021-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03800095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03800095, "Early Palliative Care for Patients With Haematological Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03800095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*